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Abstract:  Direct monitoring of singlet oxygen (
1O2) luminescence is a 
particularly challenging infrared photodetection problem. 
1O2, an excited 
state of the oxygen molecule, is a crucial intermediate in many biological 
processes. We employ a low noise superconducting nanowire single-photon 
detector to record 
1O2 luminescence at 1270 nm wavelength from a model 
photosensitizer (Rose Bengal) in solution. Narrow band spectral filtering 
and chemical quenching is used to verify the 
1O2  signal, and lifetime 
evolution with the addition of protein is studied. Furthermore, we 
demonstrate the detection of 
1O2  luminescence through a single optical 
fiber, a marked advance for dose monitoring in clinical treatments such as 
photodynamic therapy. 
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1. Introduction 
Photonic technologies play an increasingly prominent role in the life sciences and medicine 
[1]. Many important techniques rely on time correlated single photon counting (TCSPC) [2] 
at visible and near infrared (NIR) wavelengths, such as fluorescence lifetime imaging [3,4], 
monitoring fluorescence resonance energy transfer [5] and time-domain diffuse optical 
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either large-area photomultiplier tubes (PMTs) [7] or silicon single-photon avalanche diodes 
(Si SPADs) [8], with spectral range up to ~1 µm wavelength [9]. The 
1∆g excited state of 
molecular oxygen, commonly referred to as singlet oxygen, 
1O2, is important in many 
biological and physiological systems [10,11]. A specific challenge for NIR single-photon 
detection is to measure the luminescence signature of 
1O2, which occurs at around 1270 nm 
wavelength. In the clinical domain, singlet oxygen is generated in most applications of 
photodynamic therapy (PDT) via photoactivation of a photosensitizing drug (Fig. 1(a)). PDT 
is used for the treatment of solid tumors [12,13] and vascular disorders (e.g. age-related 
macular degeneration) [14]. Accurate dosimetry is needed to ensure that optimum treatment is 
delivered. Hence, measuring the concentration of 
1O2 generated during PDT, either directly or 
indirectly, has been the focus of considerable effort [10,11]. Direct luminescence detection of 
1O2 is extremely challenging, due to its extremely high reactivity that results in very low 
emission probability (~10
−8) and short lifetime (<<1 µs) in biological media. About a decade 
ago, singlet oxygen luminescence dosimetry (SOLD) became technically feasible for the first 
time [15], using specialized PMTs with extended NIR sensitivity. Studies of cells in vitro and 
tumors and other tissues in vivo [16–19] have demonstrated the validity of SOLD as a PDT 
dosimetry technique. Such studies have also illustrated the value of SOLD in a range of 
photobiological applications, from evaluating novel photosensitizers to serving as a ‘gold 
standard’ for other, indirect methods. However, the size and cost of NIR PMT detectors limits 
their widespread adoption, while their low quantum efficiency (<~1%) restricts their utility, in 
particular making it impossible to achieve single optical fiber-based light collection from 
biological samples and limiting their clinical utility. Although semiconductor based infrared 
photon counting technologies (InGaAs SPADs [9,20]) are steadily improving, in this SOLD 
demonstration we turn to an emerging superconducting single-photon detector technology 
with exceptional performance. Superconducting nanowire single-photon detectors (SNSPDs) 
[21–25] offer high infrared single-photon sensitivity, combined with picosecond timing 
resolution, low dark count rates and free running operation. The SNSPD’s low dark count rate 
is most useful in photon starved measurements, allowing longer acquisition times to be 
employed [23]. We report the first demonstration of SNSPDs for 
1O2 luminescence detection. 
We employed a fiber-coupled cavity-enhanced SNSPD with >20% practical detection 
efficiency at ~1300 nm [26], representing a 20–fold improvement in efficiency over NIR 
PMTs used to date for SOLD. The singlet oxygen signature was isolated via time-resolved 
and spectrally-filtered measurements performed on Rose Bengal (RB) in solution as a model 
photosensitizer. The free-running detector operation allows the full temporal profile of the 
photoluminescence signal to be analyzed. Quenching of the 
1O2  luminescence was 
demonstrated using sodium azide. Bovine serum albumen (BSA) was employed to simulate a 
proteinaceous biological environment; the evolution of the RB triplet and 
1O2 singlet-state 
lifetimes was successfully observed as the BSA concentration was increased. Finally, and 
most compellingly, an optical fiber delivery and collection scheme has been demonstrated as 
a breakthrough advance in SOLD for in vivo preclinical and clinical applications. 
2. Free space singlet oxygen luminescence monitoring 
Figure 1(b)  shows a schematic of the free-space optical excitation and luminescence 
collection set up. A 523 nm wavelength pulsed laser source (CrystaLaser 523-500 Nd:YLF, 
200 mW average power, 14 kHz repetition rate, 10 ns pulse width) passes through a 520 ± 10 
nm bandpass filter to eliminate longer-wavelength pump light, and a 0.5 OD neutral-density 
filter to reduce the power, before being steered through a 50 mm focal length microscope 
objective. A dichroic beam splitter (532 nm laser BrightLine®: reflection band 514-532 nm) 
diverts the beam through a second lens (25.4 mm diameter,75 mm focal length) to produce an 
expanded (~3 mm diameter, ~50 mW average power) collimated beam directed into the top of 
a 3 ml quartz cuvette filled with photosensitizer (Rose Bengal). The second plano-convex lens 
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allows selection of one of five 20 nm wide bandpass (BP) filters centered at 1210, 1240, 
1270, 1310 and 1340 nm to allow sampling of the infra-red spectrum across the 
1O2 
luminescence peak and background. Mirrors then steer the light through a 1200 nm longpass 
(LP) filter (Thorlabs FEL1200, cut-on wavelength 1200 nm) -  to further exclude short 
wavelength photons - and into a 2m long single mode (9 µm core diameter) armored telecom 
fiber. 
 
Fig. 1. (a) Jablonski (energy level) diagram for singlet oxygen (
1O2) generation in 
photodynamic therapy (PDT). 
1O2, the primary cytotoxic species in most PDT applications, is 
generated by energy transfer to triplet ground-state oxygen from the excited triplet state of a 
photosensitizer molecule: the latter is generated from the excited singlet state that results from 
light absorption by the ground-state photosensitizer. 
1O2 can return to the ground state (
3O2) 
with the emission of an infrared photon at around 1270_nm wavelength. However, due to the 
very high reaction rates of 
1O2 with biomolecules, this is an extremely rare event (~1 in 10
8) in 
cells, and the lifetime is very short (<<1 µs). (b) Set-up for free space-coupled singlet oxygen 
luminescence detection. Acronyms used: Superconducting Nanowire Single Photon Detector 
(SNSPD); Long Pass (LP); Band Pass (BP); Neutral Density (ND); Time Correlated Single 
Photon Counting (TCSPC). (c) Representative TCSPC histograms from Rose Bengal solution 
(250 µg/ml, 0.257 µM) with bandpass filters (20 nm spectral width) centered at 1210, 1240, 
1270, 1310 and 1340 nm [10 min acquisition time, 0.1024 µs bin size]. Short-lived 
fluorescence (occurring within the first µs) is present at all wavelengths studied; the key 
signature of 
1O2 is the onset and decay observed only at 1270 nm. 
Coupled to the fiber is a NbTiN SNSPD with optical cavity-enhanced performance at 
telecom wavelengths [26], housed in a closed-cycle refrigerator (Sumitomo RDK-101D cold 
head with CNA-11C air-cooled compressor, operating temperature ~3 K) [22]. The SNSPD 
has a 70 ps full width at half maximum instrument response function with a Gaussian profile. 
The detection efficiency and dark count rate of the SNSPD was calibrated as a function of 
current bias using a gain-switched 1310 nm wavelength diode laser, depolarized and 
attenuated to deliver much less than one photon per pulse. The detection efficiency was 
assumed to vary slowly across the wavelength range of the experiment. In photon-starved 
experiments, the current bias on the SNSPD can be reduced to improve the signal-to-noise; 
with decreasing bias the dark counts drop by orders of magnitude, whereas the efficiency falls 
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efficiency was 15% (defined from the point where the optical signal is launched into the 
single mode optical fiber coupled to the SNSPD inside the cryostat) and the background (or 
dark) count rate was 60 counts per second (cps). 
An electrical synchronization pulse from the laser gives the start signal of a time-
correlated single photon counting (TCSPC) hardware module (Picoquant HydraHarp with 
4_ps time binning and 20 ps FWHM timing jitter). The SNSPD output is amplified by a room 
temperature amplifier chain (3 dB, roll off 580 MHz) and acts as the stop channel. With the 
laser running at a constant pulse repetition rate of 14 kHz, the accumulation of many detector 
events allows generation of histograms (Fig. 1(c)) relating the time between a laser pulse and 
a subsequent detection event. 
Since the singlet oxygen is generated by energy transfer from the photosensitizer triplet 
state, it has been demonstrated [15] that the concentration of 
1O2 at a time, t, following a short 
illumination pulse at time t = 0 is given by 
  ( ) [ ]
1
20 exp exp ,
D
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TD T D
tt
Ot NS
τ
σ
ττ τ τ
   −− = Φ−     −    
  (1) 
where N is the number of photons in the pulse incident on the sample, [S0] is the ground-state 
photosensitizer concentration, σ is the photosensitizer ground-state absorption cross-section, 
ΦD  is  the 
1O2  quantum yield of the photosensitizer, τT  is the photosensitizer triplet-state 
lifetime, and τD is the lifetime of 
1O2. Thus, after subtracting the background signal due to 
other sources of near-infrared emission, the histogram with the 1270 nm filter should fit Eq. 
(1) [15], whereas the histograms at the other wavelengths should have different form (with 
faint 
1O2 luminescence contributions in the 1240 and 1310 nm bands). 
Figure 1(c)  shows representative histograms acquired from RB in each of the 5 
wavelength bands. A strong initial peak (duration ~1 µs) is present in all cases, due to short 
lifetime broadband fluorescence from the sample and leakage of a small fraction of the laser 
pump light into the detector channel. However, a distinct longer-lived second peak with a 
broad maximum at ~3.5 µs is observed only with the 1270 nm bandpass filter in place: this is 
the signature of singlet oxygen luminescence. Its dependence on the RB concentration is 
shown in Fig. 2(a). After initial fluorescence peak and background subtraction, a 
luminescence photon count rate of 134 counts per second (cps) was achieved with 100 µg/ml 
RB. The background (dark) count rate was ~60 cps, and the detection efficiency was ~15%. 
Equation (1) was least-squares fitted to the time-resolved histograms, after removal of the 
initial fluorescence peak (using A = Nσ[S0]ΦD, τT, τD, and a constant offset, C, as fitting 
parameters), giving values of τT = 2.3 ± 0.3 µs and τD = 3.0 ± 0.3 µs. This 
1O2 lifetime is 
consistent with typical literature values in an aqueous, biomolecule-free environment [15,18]. 
Sodium azide, NaN3, a known and highly specific singlet oxygen quencher, has been used 
in previous studies in solution and in cells with various photosensitizers to confirm that the 
1270 nm signal comes from 
1O2  radiative decay [15] and not, for example, from 
photosensitizer triplet-state phosphorescence or other NIR background. Figure 2(b) shows 
near complete loss of this signal with addition of 0.1 ml of 2 M NaN3 to 3 ml of 0.257 µM 
RB. 
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Fig. 2. (a) Total counts within 3 min histograms (after fluorescence peak and background 
subtraction), using 1270 nm band pass filtering, for increasing RB concentration. The 
reduction at the highest concentration is likely due to much higher attenuation of the excitation 
light by the increased opacity of the photosensitizer sample. (b) TCSPC histograms recorded 
from Rose Bengal (0.257_µM) with the 1270 nm bandpass filter, before and after addition of 2 
M sodium azide (3 min acquisition time, 0.1024_µs bin size). The first 1.3 µs corresponding to 
the initial fluorescence peak is ignored. The red curve is the least-squares fit to Eq. (1), for 
lifetimes τT = 2.3 ± 0.3 µs and τD = 3.0 ± 0.3 µs, taking into account a constant offset due to 
background counts (C = 39 counts per bin). 
As a further test of the origin of the 1270 nm signal, Fig. 3 shows the evolution of the 
fitted lifetimes with the addition of bovine serum albumen (BSA) to the photosensitizer, 
maintaining a constant RB concentration. Four samples were prepared, each containing 
0.026_µM RB with 0, 2, 4, and 5.4 µM BSA, respectively. The resulting lifetimes are shown 
as a function of the BSA concentration in the inset of Fig. 3. As expected, the RB triplet state 
lifetime increases markedly with binding to the protein, likely due to shielding of the 
photosensitizer from the diffusion of oxygen molecules with which the triplet state can react. 
The decrease in 
1O2 lifetime has also been seen in previous studies and was attributed to 
quenching by the protein [15]. 
 
Fig. 3. The effect of increasing BSA concentration on the Rose Bengal histograms (1270 nm 
filter, 60 min acquisition, 0.256 µs bin size). Inset: fitted lifetimes as a function of BSA 
concentration. The error bars represent the standard errors in the fits. 
#180780 - $15.00 USD Received 29 Nov 2012; revised 16 Jan 2013; accepted 17 Jan 2013; published 21 Feb 2013
(C) 2013 OSA 25 February 2013 / Vol. 21,  No. 4 / OPTICS EXPRESS  50103. Optical fiber based singlet oxygen luminescence detection 
Overall, the above results robustly confirm that the 
1O2 luminescence signal is being detected 
reliably with the SNSPD in the setup of Fig. 1(b), where the emitted light from the sample is 
first collected by free-space optics, filtered and directed into the single-mode fiber coupled to 
the detector. Whilst these results indicate exceptionally good signal-to-noise characteristics, 
this alone would not represent a paradigm shift in SOLD. The system redesign shown in Fig. 
4(a), where light is delivered and collected directly at the sample via an optical fiber, enables 
a decisive step beyond previous SOLD demonstrations. Instead of the lenses and dichroic 
beamsplitter used in the above setup (Fig. 1(b)), two separate delivery and collection fibers 
are employed (Fig. 4(a)). The laser beam is launched into a collimation package attached to a 
62.5 µm core diameter multimode graded index fiber. A collimation package on the other end 
of the fiber then produces an expanded beam (3 mm diameter) that is directed into the cuvette. 
A separate collimator/focuser collected the emitted light into 9 µm core diameter single-mode 
fiber. The light is then sent through the bandpass filters, before being coupled into the telecom 
fiber connected to the SNSPD. The TCSPC instrument was employed as before. A free-space 
section in the collection path enables the filter wheel to be employed as before for spectral 
selection, and the filtered luminescence signal is then directed to the fiber-coupled SNSPD. 
To further emulate potential in vivo (and indeed clinical) PDT treatments, the excitation light 
was also delivered via an optical fiber. The resulting time-correlated signal in each 
wavelength channel in Fig. 4(b) shows a weak but definitive signal in the 1270_nm window, 
with the same temporal features evident as in Fig. 3. Due to the poor signal-to-noise ratio, an 
accurate analysis of the lifetimes (such as that reported in Section 2) could not be performed . 
However, the loss of signal upon addition of NaN3 (Fig. 4(c)) demonstrates that this is indeed 
the 
1O2 luminescence. 
Experimental challenges in this configuration included optimization of the pump light 
delivery and alignment of the light collection scheme. While about 60% (~30 mW) of the 
free-space pump power was delivered to the sample, the collected signal was approximately 2 
orders of magnitude lower than with free-space collection, requiring long acquisition times 
(~30-60 min) to obtain a reliable measurement. In order to improve the signal-to-noise we 
reduced the current bias on the SNSPD [23], operating at 5% detection efficiency and a 
background (dark) count rate of <10 cps. Under these conditions, the system detection rate of 
the nominal 
1O2  signal was estimated to be ~0.6 cps. There is considerable scope for 
improving this setup to drive down the acquisition time. Thus, the efficiency of the 
luminescence light collection could be increased considerably by using a larger-diameter fiber 
with high numerical aperture. In-fiber filtering could be used to eliminate the losses in the 
free-space gap: this would require using several fibers, for example placed in a ring around a 
central delivery fiber, as has been used in NIR Raman spectroscopy in vivo [27]. Parallel 
signal collection using multiple detectors in a single package would then be an attractive 
option. Improving the match between the excitation wavelength and the photosensitiser 
absorption spectrum will also proportionally increase the luminescence signal: in the present 
experiments, the RB absorption coefficient at the available 523 nm laser wavelength is only 
~30% of the peak value at ~558_nm. Finally, the SNSPD technology evaluated here is itself 
advancing rapidly [24] and next-generation detectors with near 100% efficiency are under 
development [28]. 
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Fig. 4. Fiber-based delivery and collection for singlet oxygen luminescence detection. (a) 
Schematic of the experimental set up. (b) Luminescence time histograms in RB (97.367 nM) 
for the different bandpass filters (30 min acquisition time, 0.128 µs bin size), (c) Quenching 
with sodium azide [60 min acquisition time, 0.512 µs bin size]. 
4. Conclusion 
In summary, we have demonstrated for the first time the feasibility of detecting singlet 
oxygen (
1O2) luminescence using a superconducting nanowire single photon detector 
(SNSPD). In our initial experiments free-space light collection allows the luminescence to be 
coupled into the single-mode optical fiber connected to the detector, with intervening 
macroscopic bandpass filters to sample the NIR spectrum, enabling the broad background 
signal to be subtracted. The signal response to the addition of a singlet oxygen quencher 
(NaN3) and of protein (BSA), and the ability to make high-resolution time-resolved 
measurements give a high level of confidence that the signal is due to 
1O2 luminescence 
emission. This is critical, since there are many confounding factors that may give misleading 
NIR signals, especially in cells and tissues [18]. While only a single model photosensitizer 
(Rose Bengal, RB) has been used in these first proof-of-principle experiments, the findings 
should be applicable to any 
1O2-generating (i.e. Type II) photodynamic drug. Excitingly, we 
have successfully extended SOLD for the first time to single optical fiber luminescence 
collection. The  signal strength is then substantially reduced compared to the free-space 
configuration, but there are numerous technical improvements that could substantially address 
this loss, both in the optical design [27] and in the detector performance [28,29]. While the 
possibility of fiberoptic or lightguide collection of the luminescence has been investigated by 
others, these efforts have either used large diameter probes [30] and/or have not been in the 
context of time-correlated single photon counting [31]. As shown recently, the latter is critical 
for accurate SOLD measurements, because of unknown and varying background 
contributions to the NIR signal [32]. The importance of this advance lies in the potential for 
greatly widening the applications of SOLD to encompass effective in vivo SOLD monitoring 
even in a clinical context: for example, fiberoptic-based detection would allow 
1O2 
measurements in minimally-invasive endoscopic and intraoperative treatments, which are 
commonly used in photodynamic therapy of solid tumors. Furthermore, one can envisage 
placing the fiberoptic tip directly (interstitially) into the tumor or adjacent normal tissues to 
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1O2  generation at critical sites, either to ensure that adequate PDT dose is 
delivered (e.g. to the base of the tumor) and/or to reduce the risk of collateral damage to 
neighboring critical normal tissues (e.g. in the brain or, in the case of PDT treatment of 
prostate cancer, the rectal wall). Finally, 
1O2 luminescence imaging could be possible using 
2D SNSPD arrays [33,34]. This would reveal the heterogeneity of 
1O2 generation within the 
target tissue, which is important to ensure complete response: the potential value of this 
concept has been demonstrated using the conventional NIR PMT detector with raster 
scanning of the laser beam [17], but only very low resolution images were possible in a 
reasonable time, since a significant per-pixel dwell time is required to collect the time-
resolved signal. To conclude, we believe that the demonstration presented here, using 
advanced NIR detector technology to enable fiber-based SOLD for the first time, is a 
significant step forward for 
1O2 luminescence detection, and will have a profound impact in 
applications such as PDT. 
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